Skip to main content
. 2020 Jan 25;13(1):100097. doi: 10.1016/j.waojou.2019.100097

Table 2.

Baseline demographics and total number of patients in with each outcome


Urticaria, n (%)
Healthy controls
12185
104007
sex
female 8352 (68.5) 69807 (67.1)
male
3833 (31.5)
34200 (32.9)
Age at inclusion, mean
38,4 years
38,8 years
Inclusion Diagnoses
Urticaria (L50) 10500 (86.2)
Urticaria papulosa (L282) 81 (0.7)
Urticaria Solaris (L563) 128 (1.1)
Diseases related to pregnancy (O268)
185 (1.5)

Comorbidities
N (%)
Total By diagnosis After diagnosis 1 year after diagnosis Total
Mastocytosis 192 (1.6) 20 (0.2) 172 (1.4) 23 (0.2) 7 (0.0)
Anaphylaxis 73 (0.6) 33 (0.3) 40 (0.3) 21 (0.2) 72 (0.1)
Rhinoconjunctivitis 351 (2.9) 276 (2.3) 75 (0.6) 0 672 (0.6)
Atopic dermatitis 302 (2.5) 95 (0.8) 207 (1.7) 30 (0.2) 256 (0.2)
Thyroditis 40 (0.3) 11 (0.1) 29 (0.2) 22 (0.2) 153 (0.1)
Rheumatoid Arthritis 221 (1.8) 103 (0.8) 118 (1.0) 98 (0.8) 793 (0.8)
Lupus Erythematosus 40 (0.3) 20 (0.2) 20 (0.2) 0 69 (0.1)
Vitiligo 7 (0.1) 7 (0.1) 0 0 0
Depression 535 (4.4) 292 (2.4) 243 (2.0) 217 (1.8) 3058 (2.9)
Psychosis 121 (1.0) 69 (0.6) 52 (0.4) 48 (0.4) 836 (0.8)
Osteoporosis 358 (2.9) 105 (0.9) 253 (2.1) 226 (1.9) 1731 (1.7)
Peptic ulcer 127 (0.1) 52 (0.4) 75 (0.6) 68 (0.6) 732 (0.7)
Diabetes Mellitus 276 (2.3) 123 (1.0) 153 (1.3) 135 (1.1) 1812 (1.7)